UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

The New England journal of medicine, 2020-12, Vol.383 (26), p.2526-2537

2020

Volltextzugriff (PDF)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

Cochrane database of systematic reviews, 2007-10 (4), p.CD005353

2007

Volltextzugriff (PDF)

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

The lancet oncology, 2016-02, Vol.17 (2), p.153-163

2016

Volltextzugriff (PDF)

Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation

Current pharmaceutical design, 2012-12, Vol.18 (37), p.6043-6052

2012

Volltextzugriff (PDF)

Once-Weekly Semaglutide in Adults with Overweight or Obesity

The New England journal of medicine, 2021-03, Vol.384 (11), p.989-1002

2021

Volltextzugriff (PDF)

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

The lancet oncology, 2016-02, Vol.17 (2), p.200-211

2016

Volltextzugriff (PDF)

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Annals of oncology, 2020-11, Vol.31 (11), p.1553-1560

2020

Volltextzugriff (PDF)

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

The lancet oncology, 2017-05, Vol.18 (5), p.599-610

2017

Volltextzugriff (PDF)

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

JNCI : Journal of the National Cancer Institute, 2021-04, Vol.113 (4), p.400-407

2021

Volltextzugriff (PDF)

Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting

The New England journal of medicine, 2016-04, Vol.374 (14), p.1356-1367

2016

Volltextzugriff (PDF)

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

Journal of clinical oncology, 2018-01, Vol.36 (1), p.7-13

2018

Volltextzugriff (PDF)

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial

The lancet oncology, 2017-05, Vol.18 (5), p.623-630

2017

Volltextzugriff (PDF)

Adverse events in people taking macrolide antibiotics versus placebo for any indication

Cochrane database of systematic reviews, 2019-01, Vol.1 (1), p.CD011825

2019

Volltextzugriff (PDF)

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

The New England journal of medicine, 2017-10, Vol.377 (14), p.1331-1344

2017

Volltextzugriff (PDF)

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1378-1388

2020

Volltextzugriff (PDF)

Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials

JAMA : the journal of the American Medical Association, 2020-02, Vol.323 (5), p.432

2020

Volltextzugriff (PDF)

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet (British edition), 2019-11, Vol.394 (10213), p.2012-2024

2019

Volltextzugriff (PDF)

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

Annals of oncology, 2017-06, Vol.28 (6), p.1260-1267

2017

Volltextzugriff (PDF)

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v232-v243

2010

Volltextzugriff (PDF)

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Annals of oncology, 2019-12, Vol.30 (12), p.1950-1958

2019

Volltextzugriff (PDF)

Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis

Progress in neuro-psychopharmacology & biological psychiatry, 2021-07, Vol.109, p.110266-110266, Article 110266

2021

Volltextzugriff (PDF)

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

The New England journal of medicine, 2021-08, Vol.385 (6), p.503-515

2021

Volltextzugriff (PDF)

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

The New England journal of medicine, 2016-07, Vol.375 (2), p.134-142

2016

Volltextzugriff (PDF)

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Journal of the American Academy of Dermatology, 2017-08, Vol.77 (2), p.310-317.e1

2017

Volltextzugriff (PDF)

1 – 25 von 8.379

Suche als RSS-Feed

Aktive Filter

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.074)
Mit Volltextzugriff
(5.168)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(8.156)
Nausea - Chemically Induced
(7.092)
Science & Technology
(5.845)
Life Sciences & Biomedicine
(5.807)
Female
(5.300)
Vomiting - Chemically Induced
(4.413)
Male
(4.340)
Adult
(4.047)
Middle Aged
(3.929)
Aged
(2.892)
Oncology
(2.007)
Biological And Medical Sciences
(1.975)
Medical Sciences
(1.916)
Antineoplastic Agents - Adverse Effects
(1.911)
Nausea
(1.718)
Pharmacology. Drug Treatments
(1.433)
Antiemetics - Therapeutic Use
(1.392)
Nausea - Prevention & Control
(1.338)
Chemotherapy
(1.333)
Vomiting - Prevention & Control
(1.258)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(8.373)
Journals@Ovid Ovid Full Text
(3.685)
IngentaConnect
(3.407)
Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(2.642)
Single Journals
(2.050)
IngentaConnect Journals
(1.557)
Access via Wiley Online Library
(1.169)
Access via ScienceDirect (Elsevier)
(1.139)
SpringerNature Journals
(1.079)
Wiley Online Library Full Collection 2018
(847)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(798)
EZB-NALI2-00462 Springer Archive NL
(739)
Access via Taylor & Francis
(338)
Access via Taylor & Francis
(290)
Taylor & Francis Current Content Access
(286)
Access via SAGE
(277)
BMJ Journals
(247)
Access via Oxford University Press
(205)
JSTOR Archive Collection A-Z Listing
(186)
Springer Book Series
(184)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gan To Kagaku Ryoho
(307)
Supportive Care In Cancer
(292)
Cancer
(165)
Journal Of Clinical Oncology
(164)
Cancer Treatment Reports
(139)
Anesthesia And Analgesia
(109)
Bmj
(107)
American Journal Of Clinical Oncology
(101)
British Medical Journal
(100)
British Journal Of Anaesthesia : Bja
(99)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial

Adverse events in people taking macrolide antibiotics versus placebo for any indication

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Aktive Filter

Suchergebnisse filtern